LUXEMBOURG, LUXEMBOURG & HASSELT, BELGIUM – 05/12/17 | Fast Track Diagnostics S.à.r.l., one of the leading global suppliers of syndromic real-time PCR multiplexing kits, has been partnering for several months with UgenTec NV, an innovative European medical device software company that develops artificially intelligent PCR interpretation software.

From the first of January 2018, all Fast Track Diagnostics´ kits will be available on UgenTec´s FastFinder, a fully automated real-time PCR interpretation platform. This module will allow technicians to fully automate and standardise analysis of FTD´s kits with Applied Biosystems 7500 and LightCycler® 480 PCR platforms. The software will be developed for nearly all other clinical PCR machines by end of Q2 2018 and rolled out to users over that period.

The combination of Fast Track Diagnostics' kits and FastFinder’s artificial intelligence will considerably improve the processes within laboratories. The software is developed under ISO13485 standards and is CE IVD-certified.

“Fast Track Diagnostics strives constantly to deliver concrete and high quality solutions to healthcare specialists for the benefit of patients” said Bill Carman, Chief Executive Officer of Fast Track Diagnostics, “UgenTec´s knowledge on overcoming PCR interpretation challenges has brought the analysis time of FTD´s kits down to few minutes, bringing considerable efficiencies to the laboratory workflow.”

“Partnering with Fast Track Diagnostics will result in a strong increase in customer value” said Dr. Tom Martens, Managing Director at UgenTec “Their years of experience in manufacturing syndromic real-time PCR multiplexing kits combined with our IVD software knowledge will allow laboratories across the globe to decrease their eyes-on time drastically”

About Fast Track Diagnostics

Founded in 2006, Fast Track Diagnostics (FTD) is one of the leading global suppliers of real-time PCR multiplexing kits, covering all the major infectious disease groups based on the syndromic approach (respiratory infections, gastroenteritis, meningitis, etc.). Today, FTD exports over seventy kits validated on real clinical samples and detecting more than 140 viruses, bacteria, parasites and fungi to ninety countries. FTD kits are used in hundreds of public and private hospitals and laboratories around the world, and in global surveillance studies.

Want to learn more about our software?

Get access to a product webinar